BACKGROUND: Untargeted multiomics data sets are obtained for samples in systems, synthetic, and chemical biology by integrating chromatographic separations with ion mobility-mass spectrometry (IM-MS) analysis. The data sets are interrogated using bioinformatics strategies to organize the data for identification prioritization.
In parallel with big data endeavors in information technology, the past 10 years have driven allied pursuits in genomics and genome medicine. Of particular note is the use of broad-scale genome-wide association studies to correlate genetic alterations with phenotype. Beyond the genome, these foundational concepts are increasingly used in concert with advances in molecular characterization approaches for metabolome-wide association studies to correlate the dynamic molecular complement in tissues or bodily fluids with phenotype (1, 2 ) . Systemswide metabolome-wide association study strategies are now performed with the primary aim of characterizing, quantifying, and cataloging the biomolecular inventory at specific dimensions of space (e.g., cellular, tissue, or organism levels) and time (e.g., longitudinal exposure, point in the life cycle, healthy vs diseased state). These studies are broadly facilitated by the emerging capabilities of mass spectrometry (MS), 2 which can provide both targeted quantitative information and broad-scale untargeted data. The latter approaches produce largely hypothesis-independent data, which are then integrated with bioinformatics strategies to derive desired information pertaining to the question at hand. Whereas spatial information is typically obtained using a combination of different microscopy modalities and imaging MS (3, 4 ) , obtaining temporal information with high time resolution for long durations has proven more challenging because it is limited by the timescales for LC-MS and sample preparation to isolate specific classes of molecules (e.g., proteins for proteomics studies). Importantly, new data acquisition strategies coupled with informatics approaches from big data techniques have overcome many of these challenges and are highlighted here. It is anticipated that these emerging strategies will become increasingly used in the clinical setting.
Systems-wide analyses necessitate the acquisition of multidimensional data sets with separations distinguishing different physical characteristics in each dimension for high molecular selectivity. Although quantification of gene transcription is dominated by array technology, many omics endeavors, such as metabolomics, proteomics, lipidomics, and glycomics, are most commonly performed using MS or LC-MS (5 ) . In large part, this situation is attributed to the necessity of requiring massive numbers of experiments to understand metabolic and molecular networks under different conditions and the information-rich data afforded by contemporary MS instrumentation (6, 7 ) . Nevertheless, in many contemporary shotgun approaches and LC-MS and GC-MS omics studies, the class of molecule of interest (e.g., metabolites, proteins, lipids, etc.) is typically purified before analysis to reduce chemical interference from the other classes, which restricts molecular breadth in untargeted approaches. Although limiting the scope of the analysis to one or several molecular classes is potentially warranted for high quantification accuracy, large-scale systems-wide experiments motivate the development of measurement strategies that incorporate higher throughput and higher selectivity and require minimal sample manipulation. A key technology that has shown considerable promise that incorporates aspects of these features is the integration of gas-phase electrophoresis or ion mobility spectrometry (IMS) with MS (IM-MS).
Scaling Separations for High-Dimensional Data Acquisition
One of the primary challenges to broad-scale systemswide analyses is the diversity of chemical/physical properties represented in biomolecules. Clearly this breadth of diversity provides for assorted biological functions, but analytically it requires the integration of separation strategies that each provide selectivity on the basis of a different physical characteristic. Fig. 1 illustrates several common separation strategies used in the characterization of biological samples with MS and IM-MS detection.
Whereas the source of the sample may be bodily fluids, tissues, or extracts of organisms, and increasingly synthetic biological constructs, typically one or more different sample separation steps are used to tease apart the complexity of the sample. Typically liquid chromatography (LC) is used to perform separations based on hydropathy (hydrophilicity vs hydrophobicity), and gas chromatography (GC) is often used for separations based on volatility. Note that a distinction is made between separation based chromatography, or a partitioning between phases, and ion mobility and MS, for which interphase partitioning does not occur and consequently a partition coefficient cannot be determined. This lack of phase partitioning coupled with gas-phase separations distinguishes the IM and MS separation methods by the extremely fast timescales that are used for analysis (8 ) . When phase partitioning is used, the separation timescales are typically on the order of minutes to hours, whereas in IMS and MS, the separation time scales are usually on the order of microseconds to milliseconds. Thus, integrating the separations of IMS with MS (i.e., IM-MS) does not limit the throughput of the experiment, which is dominated by the chromatographic separation. Of note, because the enhancement in throughput is attained by performing the separations following ionization, a tradeoff to minimal sample preparation in IM-MS is the challenge of ion suppression effects and potentially concentration-dependent responses. Thus, for complex samples IM is oftentimes integrated with preionization chromatography, most commonly LC-IM- Typical chromatographic separation strategies used for selectivity (left) associated separation timescales (middle), and structural MS and corresponding timescales for separation and detection (right). The untargeted datasets are then processed using emerging bioinformatics/ biostatistical strategies as described in the text.
MS, to provide additional molecular selectivity while mitigating ionization effects (9 ) .
Although there exist a multitude of arrangements for performing IM-MS, untargeted analyses are commonly accepted to correspond to time-dispersive IM coupled with TOF-MS (8, 9 ) . The distinction between these methods arises in how the electric fields are applied for IM separation, namely electrodynamic IM fields (10 ) and electrostatic IM fields (11 ) , respectively. One of the primary reasons time-dispersive IM-MS has been widely adopted is because the drift time across the ion mobility cell, analogous to LC retention time, can predictably be correlated to an observed ion-neutral collision cross section (⍀, Å 2 ), which is a rotationally averaged apparent surface area of the ion. This is achieved through ionneutral collisions with an inert background buffer gas as ions traverse a drift region under the influence of the defined electric field. Larger surface area molecules experience a larger number of collisions relative to smaller surface area molecules of the same mass, which results in a longer drift time.
Importantly for untargeted analyses, different classes of molecules distribute into unique regions of IM-MS separation space or conformational space, depending on the type of molecule it is and the typical density for that class of molecule. As a result, predictable correlations emerge in the data set (mobility vs mass) related to the types of molecules analyzed and the prevailing intramolecular folding forces for each biomolecule class (12, 13 ) . This provides a rapid means for integrating omics data acquisition without the need for extensive sample preparation. Recent studies have also focused on using these correlations within a specific molecular class [e.g., lipids (14 -16 ) , carbohydrates (17, 18 ) , or peptides/proteins (19 -21 ) ] for predictive purposes (11, 22 ) . Such approaches have been demonstrated in a wide array of emerging applications, ranging from systems diagnosis of wound healing (23 ) to cancer (24, 25 ) and drug discovery (26 -28 ) . Importantly, interlaboratory studies indicate that these mobility-mass correlations exhibit very high reproducibility, making them well suited for integration in systems-wide protocols (29 ) .
Bioinformatics of High-Dimensional Data for Rapid Target Prioritization
One of the primary challenges facing IM-MS in systemswide analyses is the interrogation of massive highdimensional data sets. To illustrate the data volume in a typical LC-IM-MS experiment, an LC run of Ͻ1 h easily results in the generation of Ͼ10 4 IM separations with Ͼ10 6 corresponding MS spectra. To compound matters, typically MS/MS spectra are acquired continuously across these separation dimensions, resulting in around 10 7 to 10 8 fragmentation spectra for a single LC run. These multidimensional data place particular demands on the bioinformatics and biostatistics used to infer desired information from the systems-wide data (9 ) . In the first stage of data processing, it is complicated to extract peak features correlated across high-dimensional data. Recently, automated strategies have been developed for feature extraction from such data sets (30, 31 ) . Once features have been extracted, two avenues can be followed for projecting the multidimensional data in a visually instructive manner to guide the biological interpretation and subsequent analyses. For single-cell analyses with a A series of untargeted experiments are performed for which a separate tile is constructed for each molecular feature as a function of abundance extracted for each experimental condition, such as different time points in longitudinal exposure. After molecular detection, the map initialization step randomly generates a map with intensity profiles indicative of the data. During the self-organization training process, intensity profiles (or tiles) are grouped on the basis of similarities in an iterative process until they are matched to their closest matching profile. Once the training phase is complete and a grid location determined, heat maps are generated for each sample that are based on the intensity of the seeded features within that sample. These self-organized heat maps can then be averaged and/or differentially analyzed to distinguish regions of interest that differ among samples.
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Clinical Chemistry 62:1 (2016) 79 means for reducing the number of features per entity, such as those in labeled mass cytometry studies, advanced methods have been developed relating projection distance to cell phenotype (32, 33 ) . For systems-wide labelfree characterization, there exists a large proportion of features/molecules within the data set that do not describe the biological process, disease, or phenotype under investigation, but rather correspond to biological housekeeping and superimposed unconnected biological response to other stimuli or stresses beyond those being investigated. The motivation then is to rapidly unravel those features revealing the molecular consequences specific to the question at hand. For systems-wide feature prioritization, self-organizing map (SOM) strategies have Differential metabolic profiles were generated by MEDI to depict molecules with increased and decreased abundances from liver bioreactors exposed to 10 mmol/L APAP. The molecules in the regions of interest were subsequently identified using accurate mass measurement and high-energy MS/MS (fragmentation spectra) to search databases for candidate molecules. These representative identifications illustrate the utility of SOM analysis, grouping together metabolic pathways (such as APAP and APAP conjugates and bile acids) that were generated or perturbed upon treatment. The metabolite density plot indicates the number of molecules residing in the corresponding grid location. demonstrated great utility in performing this function (34, 35 ) . In a generalized framework, a data processing work flow for alignment and feature prioritization to discern molecular response using SOM, termed molecular expression dynamics inspector (MEDI), has been described (34 ) .
Conceptually, the SOM and MEDI approach is analogous to strategies used in a wide array of big data applications ranging from Internet commerce to discerning population behavior in civil engineering or ecology. Similarly to these applications, SOM and MEDI correlations are highlighted across multiple massive data sets. A conceptual depiction of the SOM approach is illustrated in Fig. 2 . Once data sets are obtained, for example those representing different responses to different exposures/stimuli or time points of longitudinal response, the features across the data sets are aligned and extracted. Each extracted feature forms a pattern (represented by a tile in Fig. 2) , most often the signal intensity or relative abundance of the feature as a function of the ordering of the data sets (for example, increasing time in longitudinal exposure). There is a separate tile constructed for each feature or molecule. The tiles are then sequentially compared and shifted in a recursive strategy until the tiles form neighborhoods of most similar correlated pattern, i.e., self-organization. These neighborhoods then project the high-dimensional data in a straightforward way to highlight groups of molecules that correspond to similar responses. When the initial patterns are constructed to highlight specific responses, e.g., increased/decreased expression, then the corresponding neighborhood prioritizes those features for subsequent identification from the large amount of feature data. Importantly, the patterns used for SOM do not depend on the source of data, and different sources of data can be integrated. For example, IM-MS and meta or other forms of omics data such as transcriptomics data can be used together.
One of the emerging areas in synthetic biology and medicine is the development of 3D organotypic chip platforms to emulate human organs, with the ultimate 
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Clinical Chemistry 62:1 (2016) 81 aim of constructing the so-called human-on-a-chip (36 -38 ) . These efforts are motivated, in part, to perform broad-scale toxicology experiments on human organs for system exposure to drugs as a bridge between in vitro and clinical experiments. Fig. 3 illustrates MEDI maps for longitudinal molecular mapping from a human liver bioreactor exposed to acetaminophen (APAP). The liver bioractor is seeded for culture from human cadaver liver and is perfused with media and gas distribution via hollow fibers around which the cells form the organ. The waste stream from the organ is interrogated by IM-MS with MEDI data processing over the course of 24 h following APAP exposure. In the upper portion of Fig. 3 , selected time points are illustrated mapping the molecules that are expressed in higher and lower abundance following APAP exposure. The neighborhoods forming the regions of difference direct the identification of the species, distinguishing APAP from baseline exposure. Representative molecules found in these regions are shown in the bottom of Fig. 3 to demonstrate the breadth of molecular characterization. In the seconds following APAP exposure, dysregulation of bile acid production is noted (represented by 5␣-cholestane-3␤,7␣,12␣,25,26-pentol), which is a hallmark of liver stress, and other small molecule indicators of liver health, xenobiotic conjugates, and different forms of liver dysregulation are observed.
Rapid target prioritization is also critical in chemical biology and drug discovery. Self-organizing data techniques and MEDI approaches have been used to rapidly characterize molecular indicators of drug addiction phenotype (34 ) and to prioritize candidate molecules in drug discovery efforts from natural products (39, 40 ) . The latter demonstrates a different feature of MEDI maps, namely the ability to perform mathematical operations on the untargeted data to drive further interpretive power. For example, Fig. 4 illustrates a strategy colloquially termed "bacteria fight club." In this approach, a biological system for which the genome is well characterized and known to be a reservoir of gene clusters corresponding to secondary metabolites and potentially new drug-like compounds is grown as a monoculture, such as Nocardiopsis. The difficulty lies in finding conditions that promote the expression of these secondary metabolites. Although changes to the environment and cell culture media can be exhaustively examined, coculturing the bacteria with a challenger bacterial species that competes for resources can elicit expression of secondary metabolites. To tease apart the tens of thousands of features identified in the MEDI maps of the monoculture of challenger and Nocardiopsis, the SOMs can provide the difference of the coculturing conditions, for which secondary metabolite expression is abundant to "fight" between the two organisms (40 ) . The result is a MEDI map illustrating only neighborhoods corresponding to new compounds expressed under the coculture conditions from those of the monoculture conditions. Using this approach, a few hundreds of potentially new chemical entities are prioritized for subsequent identification from tens of thousands of features observed in the bacterial cultures.
Conclusions
Systems-wide analyses are facilitated by obtaining highdimensional untargeted data through a combination of different separation strategies with ultrafast separations of IM-MS. This approach allows the integration of omics analyses without sample pretreatment to isolate classes of molecules of interest. Importantly, these data sets can be coupled with emerging bioinformatics strategies to selforganize the data to determine which features contain the desired information from massive data sets by prioritizing which features warrant identification to answer the query at hand. Such approaches are opening new avenues of inquiry in biology, medicine, and clinical diagnostics using systems-wide approaches.
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